ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
US FDA Study May Proceed letter for Cu-64 SAR-bisPSMA
Published: 07/02/22, 09:44am (AEST)•2 pages